Skip to content
OpenCapital
Get started

Fulcrum Therapeutics, Inc. FULC Q4 2024 Annual earnings

Reported February 25, 2025 · Before market open

EPS-$0.31Miss by $0.03
EPS estimate-$0.28

Next report

Aug 4, 2026 (In 6 days)
EPS estimate-$0.21

Versus estimates

Diluted EPS

Q1 2026-$0.25Beat by $0.06Q4 2025-$0.31In lineQ3 2025-$0.31Miss by $0.02Q2 2025-$0.28Beat by $0.01Q1 2025-$0.28Beat by $0.01
Q4 2024-$0.31Miss by $0.03

Ask the moment Fulcrum Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Fulcrum Therapeutics, Inc. report Q4 2024 earnings?
Fulcrum Therapeutics, Inc. (FULC) reported Q4 2024 earnings on February 25, 2025 before market open.
What were Fulcrum Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Fulcrum Therapeutics, Inc. reported eps of $-0.31 for Q4 2024.
Did Fulcrum Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.28 by $0.03.
Where can I find Fulcrum Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-026068) directly on SEC EDGAR. The filing index links above go to sec.gov.